MRC Clinical Trials Unit at UCL
Institute of Clinical Trials & Methodology
90 High Holborn
*Important information about your data (UK patients only)*
In this trial, two of our key points of interest are finding out how many people are free from distant metastases (cancer that has spread from the original tumour to other distant organs or distant lymph nodes), and how many people are still alive at the end of the trial. By looking at the data we receive from study staff at your hospital, we hope that we will be able to better understand which treatments are effective and in turn improve survival outcomes for patients.
To ensure adequate follow-up and capture of relevant mortality data for all patients that are currently enrolled in the trial, we will securely transfer your personal details such as your name, NHS number, postcode and date of birth to NHS Digital, who will obtain mortality data from the Office of National Statistics (ONS). It is NHS Digital who provide mortality data on behalf of the ONS. Please click on the link to learn more about NHS Digital https://digital.nhs.uk/article/220/Our-purpose
After obtaining ONS mortality data, we will update our trial database to ensure that we have the most up-to-date information on you. All information is stored securely at the MRC CTU at UCL and the data controller is UCL. The data will be retained for at least 10 years before archiving and according to the CTU Standard Operating Procedures. If at any point you feel that you do not want us to collect data on your survival status, then please feel free to get in touch with your hospital doctor who will inform us of your decision and we will no longer request further information about you.
The below resources are for information only.